Kwality Pharmaceuticals Successfully Completes EU-GMP Audit at Amritsar Units

Kwality Pharmaceuticals Limited has announced the successful completion of the European Union Good Manufacturing Practices (EU-GMP) audit at its Amritsar manufacturing facilities, covering both the General and Beta-Lactam units. The audit resulted in no major observations, highlighting the company's commitment to maintaining high international quality and compliance standards. This achievement strengthens Kwality Pharma's position as a trusted global pharmaceutical manufacturer across various therapeutic areas and dosage forms, enabling the company to expand its presence in regulated international markets and unlock new opportunities for growth and strategic collaborations.